In a mouse model of Alzheimer’s disease, AhR activation alleviates cognitive deficits through the upregulation of neprilysin: the main endogenous enzyme of β-amyloid catabolism [239]. The gene discussed is AHR; the disease is early-onset autosomal dominant Alzheimer disease.